UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$440M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 3 |
CRH
CRH
|
+$275M |
| 4 |
Advanced Micro Devices
AMD
|
+$228M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$213M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$538M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$473M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$397M |
| 4 |
Microsoft
MSFT
|
+$366M |
| 5 |
UnitedHealth
UNH
|
+$312M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.43% |
| 2 | Financials | 6.7% |
| 3 | Healthcare | 6.28% |
| 4 | Consumer Discretionary | 5.01% |
| 5 | Industrials | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CARM
6151
DELISTED
Carisma Therapeutics
CARM
| $62.7K | ﹤0.01% |
14,825
-578
| -4% | -$3.66K |
|
6152
Simplify Health Care ETF
PINK
$388M
| $62.5K | ﹤0.01% |
+2,491
| New | +$65.3K |
|
6153
Lineage Cell Therapeutics
LCTX
$268M
| $62.5K | ﹤0.01% |
52,971
-8,066
| -13% | -$11K |
|
6154
FTC Solar
FTCI
$40.1M
| $62.4K | ﹤0.01% |
4,872
-1,859
| -28% | -$45K |
|
6155
Fidelity Stocks for Inflation ETF
FCPI
$284M
| $62.2K | ﹤0.01% |
1,939
-74
| -4% | -$2.44K |
|
6156
BK Technologies
BKTI
$286M
| $62.1K | ﹤0.01% |
5,000
+4,958
| +11,805% | +$63K |
|
|
BZUN
6157
Baozun
BZUN
$164M
| $62.1K | ﹤0.01% |
20,038
+10,959
| +121% | +$43.8K |
|
6158
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$134M
| $62K | ﹤0.01% |
1,681
-852
| -34% | -$32.6K |
|
6159
Lands' End
LE
$391M
| $62K | ﹤0.01% |
8,297
-169
| -2% | -$1.44K |
|
6160
USCB Financial Holdings
USCB
$415M
| $62K | ﹤0.01% |
5,897
-192
| -3% | -$2.13K |
|
6161
Franklin FTSE Canada ETF
FLCA
$863M
| $62K | ﹤0.01% |
2,058
+127
| +7% | +$3.96K |
|
6162
Red Robin
RRGB
$183M
| $61.9K | ﹤0.01% |
7,702
-1,241
| -14% | -$14.8K |
|
6163
Innovator US Equity Ultra Buffer ETF November
UNOV
$110M
| $61.8K | ﹤0.01% |
2,037
-1,489
| -42% | -$46.1K |
|
6164
MicroSectors FANG+ Index 2X Leveraged ETNs due 8 Jan 2038
FNGO
$772M
| $61.7K | ﹤0.01% |
1,829
+1,399
| +325% | +$52.5K |
|
6165
Protalix BioTherapeutics
PLX
$190M
| $61.5K | ﹤0.01% |
37,060
-14,980
| -29% | -$26.9K |
|
6166
CALL
Albertsons Companies
ACI
$6.02B
| $61.4K | ﹤0.01% |
+2,700
| New | +$60.3K |
|
6167
Sensient Technologies
SXT
$5.53B
| $61K | ﹤0.01% |
1,043
-13,375
| -93% | -$843K |
|
6168
US Vegan Climate ETF
VEGN
$189M
| $61K | ﹤0.01% |
1,602
+1,135
| +243% | +$44.5K |
|
6169
Innovator Growth-100 Power Buffer ETF April
NAPR
$213M
| $60.8K | ﹤0.01% |
1,453
+1,298
| +837% | +$54.5K |
|
6170
The ONE Group
STKS
$56.5M
| $60.7K | ﹤0.01% |
11,039
-2,261
| -17% | -$15.4K |
|
|
GPGI
6171
GPGI Inc
GPGI
$3.85B
| $60.5K | ﹤0.01% |
11,291
-2,781
| -20% | -$15.5K |
|
6172
Collegium Pharmaceutical
COLL
$913M
| $60.3K | ﹤0.01% |
2,698
-8,798
| -77% | -$201K |
|
|
BNT
6173
Brookfield Wealth Solutions
BNT
$12.2B
| $60.3K | ﹤0.01% |
2,874
+676
| +31% | +$15.3K |
|
6174
Rallybio
RLYB
$88.1M
| $60.3K | ﹤0.01% |
2,235
+27
| +1% | +$1.17K |
|
6175
LeaderShares AlphaFactor Tactical Focused ETF
LSAT
$65.7M
| $60.1K | ﹤0.01% |
1,796
+1,540
| +602% | +$53.3K |
|
Similar funds
UBS Group's Q3 2023 Portfolio in Review
As of Q3 2023, UBS Group held 10,416 positions worth $290B, down 2% from $296B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q3 2023 filing shows 1,615 new, 3,254 increased, 4,100 reduced and 999 closed positions. Its largest new stake was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M. The largest sale was NVIDIA, an estimated $538M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2023 buy was Invesco S&P MidCap Quality ETF: 181,915 shares worth $14.7M.
- UBS Group added most to Invesco QQQ Trust in Q3 2023, an estimated $440M increase.
- UBS Group's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $538M.
- UBS Group fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $245M.
- UBS Group's ten largest holdings make up 15% of its $290B portfolio in Q3 2023.
- UBS Group opened 1,615 new positions and closed 999 in Q3 2023.
- UBS Group's portfolio value fell 2% quarter-over-quarter to $290B.
Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.